Nuvalent logo Nuvalent (NASDAQ:NUVL) executives highlighted ongoing regulatory milestones for the company’s lead oncology programs and discussed commercialization strategy, pipeline plans, and financial positioning during a conference fireside chat. Chief Executive Officer Jim Read More
